Month: May 2018

Notizia

Business Consultant, Notizia, Pharma Consultant

ImmusanT upgrading the management ahead of phase 2 celiac vaccine trial ImmusanT has upgraded its senior staff by appointing Daiichi...

Read More

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Zymeworks Daiichi I-O deal could potentially be worth USD 485 million Zymeworks and Daiichi Sankyo teamed up in 2016 on bispecific...

Read More

Hematopoietic Stem Cell Transplantation

Articles, Business Consultant, Pharma Consultant

Hematopoietic stem cells (HSCs) are characterized by the ability to self-renew and differentiate into all mature blood lineages. Stromal...

Read More

Takeda buys Shire in a deal worth USD 62 billion

Articles

Japan’s largest drugmaker Takeda has successfully closed a deal worth USD 62 billion to buy another pharma giant Shire grabbing a...

Read More

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Horizon Discovery declines Abcam’s USD 367 million takeover bid Horizon Discovery has recently rejected a buyout bid worth USD 367...

Read More
Close